Zanda Daneberga

View Scopus Profile

Research activity per year

Education/Academic qualification

3.1 Basic medicine, Expert, Latvian Council of Science

10 Apr 2025 → 9 Apr 2028

3.1 Basic medicine, Expert, Latvian Council of Science

2 Jun 2022 → 1 Jun 2025

3.1 Basic medicine, Expert, Latvian Council of Science

22 Aug 2019 → 21 Aug 2022

1.6 Biological sciences, Expert, Latvian Council of Science

24 Sept 2016 → 23 Sept 2019

External positions

Laboratory geneticist (ErCLG), Children's Clinical University Hospital

Oct 1998 → …

Field of Science

3.2 Clinical medicine

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where Zanda Daneberga is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

6 Active
9 Finished

Integrated Analysis of Genetic Risk Factors for Breast Cancer Development in Women with Ovarian Cancer
Čerņeikina, A. (Project leader) & Daneberga, Z. (Supervisor)
2/02/26 → 31/01/30
Project: PhD projects
LiqBio-BC: Liquid biopsy biomarkers for bladder cancer diagnostics: LiqBio-BC
Daneberga, Z. (Project leader), Miklaševičs, E. (Expert), Nakazawa (Miklasevica), M. (Leading expert), Bitiņa-Barlote, Ē. (Expert), Vjaters, E. (Leading expert), Plonis, J. (Expert), Gardovskis, J. (Leading expert), Šatcs, M. (Other), Lietuvietis, V. (Expert), Silina, S. (Other), Brasliņa, L. (Expert) & Bļizņuks, D. (Work package leader)
20/10/25 → 19/10/26
Project: National Research Programme
PREDI-LYNCH: Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome
Dominguez-Valentin, M. (Project leader), Irmejs, A. (Partner's coordinator), Poikāne, E. (Expert) & Daneberga, Z. (Leading expert)
1/09/25 → 31/08/31
Project: EU Programmes › Horizon Europe
The gut microbiome as a neoadjuvant chemotherapy response affecting factor in triple-negative breast cancer (TNBC) patients
Liepiņa, E. E. (Project leader), Daneberga, Z. (Supervisor) & Sīviņa, E. (Supervisor)
1/10/24 → 29/09/28
Project: PhD projects
Development of genetic testing strategies for hereditary breast and ovarian cancer risk prediction by analysis of spectrum of predisposing mutations and their phenotypic manifestations
Irmejs, A. (Project leader), Maksimenko, J. (Leading expert), Daneberga, Z. (Leading expert), Loža, P. (Expert), Liepiņa, E. E. (Expert), Prušakeviča, A. (Assistant (student)) & Kriķe, N. (Assistant (student))
Recovery and Resilience Facility
1/04/24 → 31/03/26
Project: Consolidation grants

27 Article
10 Meeting Abstract
4 Abstract
2 Specialist article
More

Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study
McCrary, J. M., Van Valckenborgh, E., Horgan, D., Aleksandrova, E., Bargou, R., Behulova, R. L., Belina, I., Bøhme, A. L. E., Brunet, J., Burada, F., Chirita-Emandi, A., Ciuca, A., Colas, C., Constantinidou, A., Curca, R.-O., Cursaru, V., Dalmas, M., Daneberga, Z., de Azambuja, E. & De Pauw, A. & 52 others, De Putter, R., Delikurt-Tuncalp, T., Donnelly, D., Ehrencrona, H., Foretova, L., Galli, F., Genuardi, M., Giles, R., Grima, C., Janavičius, R., Kääriäinen, H., Klink, B., Krajc, M., Kufel-Grabowska, J., Lace, B., Leitsalu, L., Le Tourneau, C., Lodahl, M., Mari, F., Matos, E., Mazzarella, L., Milagre, T. H., Mistrik, M., Moss, B., Nolan, A., O'Shea, R., Paneque, M., Patócs, A., Pestoff, R., Poirel, H. A., Risch, M., Rodrigues, M., Roetzer, K. M., Ros, A., Schröck, E., Schwaninger, G., Slámová, L., Stamatopoulos, K., Strang-Karlsson, S., Szczałuba, K., Szymczak, V., Theis, P., Turner, J., Valciņa, O., Vella, C., van Zelst-Stams, W. A. G., Wadt, K. A. W., Zschocke, J., Ronez, J., Ripperger, T., Van Den Bulcke, M. & Bergmann, A. K. (Corresponding Author), 13 Feb 2026, (E-pub ahead of print) In: European Journal of Human Genetics. 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Baseline Gut Microbiome and Metabolite Profiles Associate with Treatment Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Liepiņa, E. E., Sīviņa, E., Jurkane, L. & Daneberga, Z. (Corresponding Author), 1 Feb 2026, In: Diagnostics. 16, 3, 433.
Research output: Contribution to journal › Article › peer-review

Open Access
File
The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer
Loža, P. (Corresponding Author), Irmejs, A., Daneberga, Z., Maksimenko, J., Trofimovičs, G., Subatniece, S., Gronwald, J., Lubinski, J. & Gardovskis, J., Dec 2025, In: BMC Cancer. 25, 1, 1769.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Downloads (Pure)
The Transcriptomic Profile Underlying Somatic Monoallelic BRCA1 Inactivation: A Biomarker for Breast Cancer Prognosis
Kuzņecova, E., Nakazawa (Miklasevica), M., Kriķe, N., Šatcs, M., Sīviņa, E., Irmejs, A., Loža, P., Gardovskis, J., Miklaševičs, E. & Daneberga, Z. (Corresponding Author), 14 Aug 2025, In: Diagnostics. 15, 16, 16 p., 2037.
Research output: Contribution to journal › Article › peer-review

Open Access
File
13 Downloads (Pure)
Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning
Bitiņa-Barlote, Ē. (Corresponding Author), Bļizņuks, D., Silina, S., Šatcs, M., Vjaters, E., Lietuvietis, V., Nakazawa (Miklasevica), M., Plonis, J., Miklaševičs, E., Daneberga, Z. & Gardovskis, J., 18 Feb 2025, In: Diagnostics. 15, 4, 16 p., 492.
Research output: Contribution to journal › Article › peer-review

Open Access
File
2 Citations (Scopus)

7 Downloads (Pure)

Urine microRNA in Septic Neonates
Daneberga, Z. (Creator), Miklaševičs, E. (Creator), Nakazawa (Miklasevica), M. (Creator), Šatcs, M. (Creator), Sniedze, D. (Creator) & Gardovska, D. (Creator), Riga Stradins University, 19 Dec 2024
DOI: 10.48510/FK2/4BK66S, https://dataverse.rsu.lv/dataset.xhtml?persistentId=doi:10.48510/FK2/4BK66S
Dataset
Microbiome of Preterm Neonates (Control + Patents with Necrotising Enterocolitis)
Karlsons, J. (Creator), Daneberga, Z. (Creator), Kroiča, J. (Creator), Miklaševičs, E. (Creator), Nakazawa (Miklasevica), M. (Creator), Liepiņa, E. E. (Creator), Broks, R. (Creator), Skadiņš, I. (Creator), Gardovska, D. (Creator), Asare, L. (Creator), Rozentālberga, A. (Creator) & Ābola, Z. (Creator), Riga Stradins University, 11 Dec 2024
DOI: 10.48510/FK2/ROG2VH, https://dataverse.rsu.lv/dataset.xhtml?persistentId=doi:10.48510/FK2/ROG2VH
Dataset
miRNA Expression and Clinical Data in the Urinary Bladder Cancer and Control Cohort
Gardovskis, J. (Creator), Daneberga, Z. (Creator), Vjaters, E. (Creator), Lietuvietis, V. (Creator), Bļizņuks, D. (Creator), Bitiņa-Barlote, Ē. (Creator), Plonis, J. (Creator), Miklaševičs, E. (Creator), Silina, S. (Creator) & Šatcs, M. (Creator), Riga Stradins University, 13 Dec 2024
DOI: 10.48510/FK2/LZXMXB, https://dataverse.rsu.lv/dataset.xhtml?persistentId=doi:10.48510/FK2/LZXMXB
Dataset
Transcriptomes From Hepatocellular Carcinoma and Normal Liver Tissues
Miklaševičs, E. (Creator), Vilmanis, J. (Creator) & Daneberga, Z. (Creator), Riga Stradins University, 10 Sept 2025
DOI: 10.48510/FK2/00NG93, https://doi.org/10.48510/FK2/00NG93
Dataset

Stronger Together-How ERN GNTURIS Connect Experts Across Europe for Better Care
Daneberga, Z. (Invited speaker) & Oliveira, C. (Speaker)
6 Jan 2026
Activity: Talk or presentation types › Invited talk
Precision Medicine Networking Forum 2025
Daneberga, Z. (Session chair)
9 Oct 2025 → 10 Oct 2025
Activity: Participating in or organising an event types › Organising a conference, workshop, ...
Precision Medicine Networking Forum 2025
Daneberga, Z. (Organising committee member)
9 Oct 2025 → 10 Oct 2025
Activity: Participating in or organising an event types › Organising a conference, workshop, ...
ERN GENTURIS (External organisation)
Daneberga, Z. (Member)
4 Jul 2025 → …
Activity: Membership types › Membership of network

Ģimenē bijis krūts vai olnīcu vēzis? RSU pētnieku ieteikumi sievietēm ar iespējamu pārmantotas slimības risku
Irmejs, A. & Daneberga, Z.
10/09/25
1 Media contribution
Press/Media
Research from Institute of Oncology Provides New Data on Breast Cancer (Identification of Altered Transcripts and Pathways in Triple Negative Breast Cancer)
Daneberga, Z., Irmejs, A., Berga-Svitina, E., Miklaševičs, E., Nakazawa (Miklasevica), M. & Gardovskis, J.
29/03/23
1 item of Media coverage
Press/Media
Atšifrēt cilvēka genomu ir teju tas pats, kā lasīt valodā, kuru nesaprotam
Daneberga, Z.
14/06/22
1 Media contribution
Press/Media
Pārmantots krūts un olnīcu vēzis: ģenētiskā testēšana, agrīna diagnostika, personalizēta terapija un riska samazināšana
Daneberga, Z., Irmejs, A., Loža, P., Maksimenko, J., Subatniece, S. & Gardovskis, J.
1/02/22
1 item of Media coverage
Press/Media
CRISPR metode. Gēnu rediģēšanas panākumi pēdējos gados radījuši diskusijas metodes ētiku
Neiders, I. & Daneberga, Z.
16/12/21
1 Media contribution
Press/Media

Zanda Daneberga

Personal profile

Education/Academic qualification

External positions

Field of Science

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Integrated Analysis of Genetic Risk Factors for Breast Cancer Development in Women with Ovarian Cancer

LiqBio-BC: Liquid biopsy biomarkers for bladder cancer diagnostics: LiqBio-BC

PREDI-LYNCH: Validated non-invasive liquid biopsy tests for cancer PREDIction in LYNCH Syndrome

The gut microbiome as a neoadjuvant chemotherapy response affecting factor in triple-negative breast cancer (TNBC) patients

Development of genetic testing strategies for hereditary breast and ovarian cancer risk prediction by analysis of spectrum of predisposing mutations and their phenotypic manifestations

Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study

Baseline Gut Microbiome and Metabolite Profiles Associate with Treatment Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

The difference in contralateral breast cancer and ovarian cancer risks for BRCA1 founder variant (c.5266dup, c.4035del) carriers with primary breast cancer

The Transcriptomic Profile Underlying Somatic Monoallelic BRCA1 Inactivation: A Biomarker for Breast Cancer Prognosis

Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning

Urine microRNA in Septic Neonates

Microbiome of Preterm Neonates (Control + Patents with Necrotising Enterocolitis)

miRNA Expression and Clinical Data in the Urinary Bladder Cancer and Control Cohort

Transcriptomes From Hepatocellular Carcinoma and Normal Liver Tissues

Stronger Together-How ERN GNTURIS Connect Experts Across Europe for Better Care

Precision Medicine Networking Forum 2025

Precision Medicine Networking Forum 2025

ERN GENTURIS (External organisation)

Ģimenē bijis krūts vai olnīcu vēzis? RSU pētnieku ieteikumi sievietēm ar iespējamu pārmantotas slimības risku

Research from Institute of Oncology Provides New Data on Breast Cancer (Identification of Altered Transcripts and Pathways in Triple Negative Breast Cancer)

Atšifrēt cilvēka genomu ir teju tas pats, kā lasīt valodā, kuru nesaprotam

Pārmantots krūts un olnīcu vēzis: ģenētiskā testēšana, agrīna diagnostika, personalizēta terapija un riska samazināšana

CRISPR metode. Gēnu rediģēšanas panākumi pēdējos gados radījuši diskusijas metodes ētiku

Zanda Daneberga

Personal profile

Education/Academic qualification

External positions

Field of Science

Expertise related to UN Sustainable Development Goals

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output

Datasets

Activities

Press/Media